5-138930863-C-G

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001903.5(CTNNA1):​c.2226C>G​(p.Val742Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0228 in 1,613,280 control chromosomes in the GnomAD database, including 550 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V742V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.020 ( 37 hom., cov: 32)
Exomes 𝑓: 0.023 ( 513 hom. )

Consequence

CTNNA1
NM_001903.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.121

Publications

9 publications found
Variant links:
Genes affected
CTNNA1 (HGNC:2509): (catenin alpha 1) This gene encodes a member of the catenin family of proteins that play an important role in cell adhesion process by connecting cadherins located on the plasma membrane to the actin filaments inside the cell. The encoded mechanosensing protein contains three vinculin homology domains and undergoes conformational changes in response to cytoskeletal tension, resulting in the reconfiguration of cadherin-actin filament connections. Certain mutations in this gene cause butterfly-shaped pigment dystrophy. [provided by RefSeq, May 2016]
CTNNA1 Gene-Disease associations (from GenCC):
  • CTNNA1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • patterned macular dystrophy 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • patterned macular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 5-138930863-C-G is Benign according to our data. Variant chr5-138930863-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 224932.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.121 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0196 (2993/152326) while in subpopulation AMR AF = 0.0296 (453/15304). AF 95% confidence interval is 0.0274. There are 37 homozygotes in GnomAd4. There are 1425 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2993 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001903.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNA1
NM_001903.5
MANE Select
c.2226C>Gp.Val742Val
synonymous
Exon 16 of 18NP_001894.2A0A384MDY0
CTNNA1
NM_001323982.2
c.2226C>Gp.Val742Val
synonymous
Exon 17 of 19NP_001310911.1P35221-1
CTNNA1
NM_001323983.1
c.2226C>Gp.Val742Val
synonymous
Exon 16 of 18NP_001310912.1A0A384MDY0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNA1
ENST00000302763.12
TSL:1 MANE Select
c.2226C>Gp.Val742Val
synonymous
Exon 16 of 18ENSP00000304669.7P35221-1
CTNNA1
ENST00000518825.5
TSL:1
c.2226C>Gp.Val742Val
synonymous
Exon 15 of 18ENSP00000427821.1G3XAM7
CTNNA1
ENST00000540387.5
TSL:1
c.1116C>Gp.Val372Val
synonymous
Exon 10 of 12ENSP00000438476.1P35221-3

Frequencies

GnomAD3 genomes
AF:
0.0197
AC:
2994
AN:
152208
Hom.:
37
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00466
Gnomad AMI
AF:
0.0669
Gnomad AMR
AF:
0.0296
Gnomad ASJ
AF:
0.0317
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0226
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0275
Gnomad OTH
AF:
0.0244
GnomAD2 exomes
AF:
0.0198
AC:
4984
AN:
251464
AF XY:
0.0197
show subpopulations
Gnomad AFR exome
AF:
0.00486
Gnomad AMR exome
AF:
0.0168
Gnomad ASJ exome
AF:
0.0286
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0232
Gnomad NFE exome
AF:
0.0288
Gnomad OTH exome
AF:
0.0269
GnomAD4 exome
AF:
0.0232
AC:
33835
AN:
1460954
Hom.:
513
Cov.:
30
AF XY:
0.0226
AC XY:
16425
AN XY:
726866
show subpopulations
African (AFR)
AF:
0.00433
AC:
145
AN:
33454
American (AMR)
AF:
0.0177
AC:
792
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0276
AC:
722
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39694
South Asian (SAS)
AF:
0.00285
AC:
246
AN:
86240
European-Finnish (FIN)
AF:
0.0240
AC:
1282
AN:
53420
Middle Eastern (MID)
AF:
0.0186
AC:
107
AN:
5766
European-Non Finnish (NFE)
AF:
0.0263
AC:
29242
AN:
1111156
Other (OTH)
AF:
0.0215
AC:
1298
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
1446
2892
4339
5785
7231
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1056
2112
3168
4224
5280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0196
AC:
2993
AN:
152326
Hom.:
37
Cov.:
32
AF XY:
0.0191
AC XY:
1425
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00464
AC:
193
AN:
41580
American (AMR)
AF:
0.0296
AC:
453
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0317
AC:
110
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4826
European-Finnish (FIN)
AF:
0.0226
AC:
240
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0275
AC:
1870
AN:
68032
Other (OTH)
AF:
0.0241
AC:
51
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
144
287
431
574
718
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0240
Hom.:
15
Bravo
AF:
0.0201
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0289
EpiControl
AF:
0.0296

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Hereditary diffuse gastric adenocarcinoma (1)
-
-
1
Hereditary nonpolyposis colon cancer (1)
-
-
1
not specified (1)
-
-
1
Patterned macular dystrophy 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
8.6
DANN
Benign
0.71
PhyloP100
0.12
PromoterAI
-0.029
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11552052; hg19: chr5-138266552; COSMIC: COSV57071184; API